Kuehn Law Encourages Investors of LivePerson, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - July 2, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of LivePerson, Inc. (NASDAQ: LPSN) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, LivePerson insiders caused the company to (i) maintain a significant deficiency in its disclosure controls and procedures; (ii) as a consequence, LivePerson's internal controls over financial reporting were...
2024-07-02 9:48 AM EDT
Kuehn Law Encourages Investors of Schrodinger, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - May 16, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Schrodinger, Inc. (NASDAQ: SDGR) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you own SDGR please contact Justin Kuehn, Esq. by email at justin@kuehn.law or call (833) 672-0814. The consultation and...
2024-05-16 10:39 AM EDT
Kuehn Law Encourages Investors of Relmada Therapeutics, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - May 16, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Relmada Therapeutics, Inc. (NASDAQ: RLMD) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you own RLMD please contact Justin Kuehn, Esq. by email at justin@kuehn.law or call (833) 672-0814. The...
2024-05-16 10:37 AM EDT
Kuehn Law Encourages Investors of Zentalis Pharmaceuticals, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - May 16, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you own ZNTL please contact Justin Kuehn, Esq. by email at justin@kuehn.law or call (833) 672-0814. The...
2024-05-16 10:36 AM EDT
Kuehn Law Encourages Investors of ImmunityBio, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - May 16, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of ImmunityBio, Inc. (NASDAQ: IBRX) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you own IBRX please contact Justin Kuehn, Esq. by email at justin@kuehn.law or call (833) 672-0814. The consultation and...
2024-05-16 10:33 AM EDT
Kuehn Law Encourages Investors of Intellia Therapeutics, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - May 16, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Intellia Therapeutics, Inc. (NASDAQ: NTLA) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you own NTLA please contact Justin Kuehn, Esq. by email at justin@kuehn.law or call (833) 672-0814. The...
2024-05-16 10:31 AM EDT
Kuehn Law Encourages Investors of Regeneron Pharmaceuticals, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - May 16, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you own REGN please contact Justin Kuehn, Esq. by email at justin@kuehn.law or call (833) 672-0814. The...
2024-05-16 10:28 AM EDT
Kuehn Law Encourages Investors of SpringWorks, Therapeutics Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - May 16, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you own SWTX please contact Justin Kuehn, Esq. by email at justin@kuehn.law or call (833) 672-0814. The...
2024-05-16 10:25 AM EDT
Kuehn Law Encourages Investors of Relmada Therapeutics, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - May 3, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Relmada Therapeutics, Inc. (NASDAQ: RLMD) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you own RLMD please contact Justin Kuehn, Esq. by email at justin@kuehn.law or call (833) 672-0814. The...
2024-05-03 3:30 PM EDT
Kuehn Law Encourages Investors of Zentalis Pharmaceuticals, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - May 3, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you own ZNTL please contact Justin Kuehn, Esq. by email at justin@kuehn.law or call (833) 672-0814. The...
2024-05-03 10:48 AM EDT
Kuehn Law Encourages Long-Term Investors of Celularity Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - April 22, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Celularity, Inc. (NASDAQ: CELU) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you own CELU and purchase BEFORE June 2022 please contact Justin Kuehn, Esq. by email at justin@kuehn.law or call (833)...
2024-04-22 1:46 PM EDT
Kuehn Law Encourages Investors of Ginkgo Bioworks Holdings, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - March 15, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you own DNA please contact Justin Kuehn, Esq. by email at justin@kuehn.law or call (833) 672-0814. The...
2024-03-15 12:54 PM EDT
Kuehn Law Encourages Investors of ImmunityBio, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - March 15, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of ImmunityBio, Inc. (NASDAQ: IBRX) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you own IBRX please contact Justin Kuehn, Esq. by email at justin@kuehn.law or call (833) 672-0814. The consultation and...
2024-03-15 12:51 PM EDT
Kuehn Law Encourages Investors of Guardant Health, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - March 15, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Guardant Health, Inc. (NASDAQ: GH) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you own GH please contact Justin Kuehn, Esq. by email at justin@kuehn.law or call (833) 672-0814. The consultation and...
2024-03-15 12:46 PM EDT
Kuehn Law Encourages Investors of Ultragenyx Pharmaceutical, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - March 15, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Ultragenyx Pharmaceutical, Inc. (NASDAQ: RARE) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you own RARE please contact Justin Kuehn, Esq. by email at justin@kuehn.law or call (833) 672-0814. The...
2024-03-15 12:43 PM EDT
Kuehn Law Encourages Investors of Intellia Therapeutics, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - March 15, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Intellia Therapeutics, Inc. (NASDAQ: NTLA) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you own NTLA please contact Justin Kuehn, Esq. by email at justin@kuehn.law or call (833) 672-0814. The...
2024-03-15 12:40 PM EDT
Kuehn Law Encourages Investors of Regeneron Pharmaceuticals, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - March 14, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you own REGN please contact Justin Kuehn, Esq. by email at justin@kuehn.law or call (833) 672-0814. The...
2024-03-14 2:40 PM EDT
Kuehn Law Encourages Investors of Celularity Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - March 14, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Celularity, Inc. (NASDAQ: CELU) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you own CELU please contact Justin Kuehn, Esq. by email at justin@kuehn.law or call (833) 672-0814. The consultation and...
2024-03-14 2:39 PM EDT
Kuehn Law Encourages Investors of Relay Therapeutics, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - March 14, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Relay Therapeutics, Inc. (NASDAQ: RLAY) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you own RLAY please contact Justin Kuehn, Esq. by email at justin@kuehn.law or call (833) 672-0814. The...
2024-03-14 2:00 PM EDT
Kuehn Law Encourages Investors of SpringWorks, Therapeutics Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - March 14, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you own SWTX please contact Justin Kuehn, Esq. by email at justin@kuehn.law or call (833) 672-0814. The...
2024-03-14 1:52 PM EDT